Mutant p53 gain of function mediates cancer immune escape that is counteracted by APR-246.
Xiaolei ZhouGema Sanz SantosYue ZhanMariana M S OliveiraShiva RezaeiMadhurendra SinghSylvain PeugetLisa S WesterbergJohn Inge JohnsenGalina SelivanovaPublished in: British journal of cancer (2022)
Breast carcinomas with mtp53 displayed enhanced inflammation. APR-246 boosted the interferon response or represses immune checkpoints in p53 mutant tumour cells, and restores cancer immune surveillance in vivo.